Danaher stock slides 2.12% and underperforms competitors

5 articles · Updated · MarketWatch · May 1

Shares closed at $175.15 as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones Industrial Average fell 0.31% to 49,499.27.
Danaher lagged peers including Thermo Fisher, down 2.04%, Abbott, down 1.46%, and Medtronic, down 1.20%, during Friday's mixed market session.
The stock finished 27.86% below its 52-week high of $242.80 reached on 22 January, while trading volume of 3.9 million stayed below its 50-day average.

Analysts say 'Buy' but the stock keeps falling. What does Wall Street see in Danaher that the market is missing?

Is Danaher's $9.9B Masimo bet a strategic pivot or a costly distraction from its core business challenges?